As per the data from the Registry of the International Society of Heart and Lung transplantation, the number of reported heart transplants has increased slowly in the recent years, especially in North America. The overall prevalence of CAV in post-cardiac transplant patients at 1, 5 and 10 years is 8, 30 and 50% respectively.
Cardiac allograft vasculopathy epidemiology and demographics
Graft-versus-host disease epidemiology and demographics
Sarcoidosis epidemiology and demographics
Microscopic polyangiitis epidemiology and demographics
Cardiac allograft vasculopathy pathophysiology
Wegeners granulomatosis epidemiology and demographics
Polyarteritis nodosa epidemiology and demographics
Amyloidosis epidemiology and demographics